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Purpose: The present study concerns traumatic hyphemas and their prognostic factors and signs. 
The aim of this study is to determine the prognostic factors and signs of traumatic hyphemas.
Methods: During the last ﬁ  ve years, 72 young individuals were hospitalized with the diagnosis 
of suffering a traumatic hyphema and were divided in three groups according to the extent of 
their hyphema. The ﬁ  rst group concerns 38 patients with a small hyphema 3–4 mm, the second 
group concerns 22 patients with moderate hyphema reaching the pupillary border, and the third 
group concerns 12 patients with a total hyphema.
Results: The hyphema was absorbed in 63 patients and the IOP was controlled with medical 
treatment after 3–24 days. However, surgical management was necessary for two patients. 
Finally, antiglaucomatous treatment was administered in seven patients with persistent high 
intraocular pressure.
Conclusions: The important clinical signs that determine the prognosis of such hyphemas are 
the size of hyphema, the blood color, recurrent hemorrhage, the absorption time, the increase 
of intraocular pressure, and blood staining of the cornea.
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Introduction
A hyphema is the presence of blood in the anterior chamber and the two most common 
causes are trauma of the globe and eye surgery. Other causes are iris neovascularization 
(eg, in diabetic retinopathy, central retinal vein occlusion, or chronic retinal 
detachment), juvenile xanthogranuloma, melanoma of the iris, myotonic dystrophy, 
leukemia, thrombopenia, von Willebrand disease, etc.1–3
The mean annual incidence of hyphemas is approximately 17 patients in 100,000, with 
a peak incidence between 10 and 20 years. The mean age of presentation is 25 years.1
In urban areas, two thirds of traumatic hyphemas are due to blunt ocular trauma 
and only one third due to traumatic rupture of the globe.1 Blunt ocular traumas caused 
by injury of the globe or peribulbar tissues and are followed by an anteroposterior 
compression of the globe and a simultaneous elongation of the equatorial area. 
This results in pressure on the anatomic components of the anterior segment, in rupture 
of iris or ciliary body’s blood vessels and ﬁ  nally in hemorrhage in the anterior chamber 
(Figure 1). The hemorrhage may occupy the total volume of the anterior chamber, but 
usually occupies only a part of it, creating a level due to gravity effect.1–4 Secondary 
hemorrhage may occur because of blood clot dissolution and contraction of the 
traumatized vessels.5,6 Another mechanism of hyphema creation, in case of blunt ocular 
trauma, is the direct damage of blood vessels and the post-traumatic hypotony.1,2,4
Methods
This study investigates the factors that relate to the prognosis of the anterior chamber 
hyphemas caused by blunt ocular traumas.Clinical Ophthalmology 2009:3 288
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Seventy-two patients were included, they were treated 
at the 1st University Eye Clinic of Athens, Greece and their 
demographic characteristics are displayed in Table 1.
Two of the patients that were included in the study had 
the sickle cell trait and one patient was on anticoagulant 
medication.
At the baseline examination, a detailed history was taken 
about the speciﬁ  c circumstances under which the trauma 
took place and also a general medical history about other 
diseases (anemia, blood disorders, medications used, and 
liver or kidney disease) (Tables 2 and 3).
The eye examination included a detailed examination 
at the slit-lamp, intraocular pressure (IOP) measurement, 
fundus examination when it was possible (clear ocular media) 
with a +78 diopter lens or with the indirect ophthalmoscope. 
There was no use of the three-mirror Goldmann or any other 
type of goniolens during the initial examination in order to 
avoid any pressure on the globe and a secondary hemorrhage. 
We performed a gonioscopy after the hyphema was absorbed 
to check for the presence of a possible angle recession.
In certain cases, the patient underwent a computed tomog-
raphy (CT) scan, magnetic resonance imaging (MRI) of the 
orbit, or a β-ultrasonography with special care taken not to 
exert pressure on the globe.
During the hospital treatment, patients had a daily slit-lamp 
examination and IOP measurement twice daily. According to 
the hyphema height the patients were divided in three groups: In 
the ﬁ  rst group, 38 patients were included with a small hyphema 
(3–4 mm height; Figure 2); the second group had 22 patients 
with a moderate hyphema (Figure 3) reaching the pupillary 
border; the third group had 12 patients with a severe hyphema 
involving the total volume of the anterior chamber.
Intervention results
Treatment strategy comprises a supine position in bed with 
elevation of the head at an angle of 30°–45° in order to 
facilitate blood precipitation and absorption. In this way we 
contribute to the prevention of complications.
Medication in all patients encompasses topical steroid 
drops and a mild mydriatic. In certain patients in which an IOP 
elevation was observed, we used drops of a β-blocker and/or a 
carbonic anhydrase inhibitor, and in signiﬁ  cant IOP elevation 
we introduced a carbonic anhydrase inhibitor per os.
In the majority of the patients (63 patients; 87.5%) 
treatment results were satisfying with adequate control of the 
IOP and resolution of the hyphema in a period of 3–24 days.
Secondary hemorrhage was observed the 3rd day in one 
patient and the 4th day in two others. One of them had the 
sickle cell trait, another was on anticoagulant medication that 
had discontinued immediately after the occurrence of the 
hyphema, and the third patient suffered a moderate hyphema 
without any known predisposing factor.
Two patients in the 3rd group had an hyphema with a 
duration of more than 20 days and a sustained increased IOP, 
so they underwent surgery to evacuate the blood from the 
anterior chamber and to create a peripheral iridectomy.
Seven patients of the same group, after the absorption 
of the blood, suffered a persistent increase of the IOP above 
the higher normal limits and they were treated as open angle 
glaucoma patients. All of them were controlled medically 
except one patient who also had a vitreous hemorrhage. 
It was diagnosed as a ghost-cell glaucoma and underwent 
vitrectomy to control the elevated IOP. Among the patients 
that needed antihypertensive medication, gonioscopy 
revealed angle recession in three.
Table 1 Demographic characteristics
No. of patients 72
Age 15–47 Mean age, 24.4 years
Sex 58 men, 14 women
Race 70 Caucasian, 2 non-Caucasian
Table 2 Causes of hyphema-related trauma
Affray/beating 33
Sport activities 24
Car accidents 7
Industrial accidents 4
Other causes 4
Figure 1 Patient with a moderate hyphema, iridoplegia, laceration of the pupillary 
sphincter at 9 o’clock and conjuctival hemorrhage at the site of globe injury.Clinical Ophthalmology 2009:3 289
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Discussion
The most important clinical signs that relate to the prognosis 
of traumatic hyphema, according to our experience and 
current literature1–21 are the following:
The hyphema height
Small hyphemas with a height of 3–4 mm, usually have a 
favorable course, which means that the anterior chamber 
hemorrhage is absorbed during the 1st week after the injury 
without any other complications. On the contrary, as far as it 
concerns the prognosis of the moderate and especially of the 
severe hyphemas, we should be quite skeptical.1,7,8
Reoccurrence of hemorrhage
Reoccurrence of hemorrhage is usually observed between 
the 3rd and 5th day and is a consequence of the normal 
blood clot dissolution that takes place at the site at which the 
blood vessel was traumatized. The secondary hemorrhage 
is usually heavier, occupies the total volume of the anterior 
chamber, and according to various sources is encountered 
with a frequency of 0.4% to 38%.1,5,6,11 In our study, secondary 
hemorrhage occurred in three patients (4%). Two were high 
risk patients for re-bleeding (sickle cell trait and anticoagulant 
medication).5,6,7,16
Blood color
Light red color is indicative of a continuous circulation of 
the aqueous humor and of an efﬁ  cient oxygen supply in the 
anterior chamber. On the contrary, dark red or black color 
of the blood (due to the transformation of hemoglobin in 
methemoglobin) shows the discontinuation of the aqueous 
humor circulation and the lack of oxygen in the anterior 
chamber, which means the prognosis of hyphema must be 
made very cautiously.12
IOP elevation
Intraocular pressure elevation is the primary and most seri-
ous complication of hyphema because a major elevation 
of the IOP could cause corneal staining and optic nerve 
atrophy.10,13,16,17 The IOP ﬂ  uctuation after an injury of the 
globe is as follows:
1.  A moderate elevation (24 mmHg) immediately after the 
injury with a duration of 6–18 hours, due to mechanical 
obstruction of the trabecular meshwork from blood con-
stituents and inﬂ  ammatory debris. In addition, there can 
be a direct injury and a following edema of the trabecular 
meshwork.
2.  Recovery of the IOP in normal values or even hypotony. The 
latter is observed from the 2nd until the 4th or 5th day and 
increases signiﬁ  cantly the risk of a secondary hemorrhage. 
The cause of the hypotony is the reduction of the aqueous 
humor production due to ciliary body trauma.
3.  Gradual increase of the IOP beginning the 5th–6th day 
that can reach high values. The reason for this phenom-
enon is dual: the return of the ciliary body function and the 
sustained obstruction of the aqueous humor circulation.
Figure 2 Patient with a small hyphema.
Table 3 Sport activities related to traumatic hyphemas
Tennis 8
Basketball 5
Water polo 4
Football 4
Volleyball 3
Figure 3 Patient with a moderate hyphema.Clinical Ophthalmology 2009:3 290
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4.  A return of the IOP in normal values due to the absorption 
of the blood and the reinstitution of the trabecular 
meshwork function after approximately 4–18 days. 
Despite this, a secondary metatraumatic glaucoma may 
be established.
Corneal blood staining
A long standing hemorrhage of the anterior chamber along 
with a high IOP may cause blood constituents to enter 
the cornea and result in discoloration of the cornea with a 
yellow or light brown color. Other factors that contribute to 
this complication are the damage and transformation of the 
corneal endothelial cells and microerosions of the membrane 
of Descemet as a consequence of the trauma.14,20,21 Corneal 
blood staining may persist for a long period and its absorption 
starts from the periphery towards the centre of the cornea.
Conclusions
As a conclusion, the prognosis of the traumatic hyphema 
depends on the hyphema height, its color, the reoccurrence of 
the hemorrhage, the time that takes for the anterior chamber 
to clear the blood, and mostly on the IOP rise and the cor-
neal blood staining. Patients with predisposing factors are 
associated with a higher risk of complications and should be 
more closely followed.
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